ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base …

S Dorbala, Y Ando, S Bokhari… - Circulation …, 2021‏ - ahajournals.org
Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …

A test in context: myocardial strain measured by speckle-tracking echocardiography

P Collier, D Phelan, A Klein - Journal of the American College of …, 2017‏ - jacc.org
Strain-based imaging techniques (and specifically speckle-tracking echocardiography) have
been shown to have clinical utility in a variety of settings. This technique is being embraced …

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

P Garcia-Pavia, C Rapezzi, Y Adler, M Arad… - European heart …, 2021‏ - academic.oup.com
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D …

P Garcia‐Pavia, C Rapezzi, Y Adler… - European journal of …, 2021‏ - Wiley Online Library
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E …

J Čelutkienė, R Pudil… - European journal of …, 2020‏ - Wiley Online Library
Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …

Systemic amyloidosis

AD Wechalekar, JD Gillmore, PN Hawkins - The Lancet, 2016‏ - thelancet.com
Tissue deposition of protein fibrils causes a group of rare diseases called systemic
amyloidoses. This Seminar focuses on changes in their epidemiology, the current approach …

Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment

OK Siddiqi, FL Ruberg - Trends in cardiovascular medicine, 2018‏ - Elsevier
The amyloidoses are a group of systemic diseases characterized by organ deposition of
misfolded protein fragments of diverse origins. The natural history of the disease …

Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction

K Kalam, P Otahal, TH Marwick - Heart, 2014‏ - heart.bmj.com
Background Global longitudinal strain (GLS) is a robust, well validated and reproducible
technique for the measurement of LV longitudinal deformation. We sought to assemble …

JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis

H Kitaoka, C Izumi, Y Izumiya, T Inomata, M Ueda… - Circulation …, 2020‏ - jstage.jst.go.jp
[CQ1] What is the role of 99 mTc-PYP scintigraphy (bone scintigraphy) in clinical practice for
CA?∙∙∙∙∙∙ 1655 [CQ2] The role of endomyocardial biopsy. Which site is appropriate for biopsy …

Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis

CV Edwards, N Rao, D Bhutani… - Blood, The Journal …, 2021‏ - ashpublications.org
Systemic immunoglobulin light-chain amyloidosis is characterized by pathologic deposition
of immunoglobulin light chains as amyloid fibrils in vital organs, leading to organ impairment …